226 Chapter 10 References 1. GBD 2019 Antimicrobial Resistance Collaborators. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022;400(10369):2221-2248. 2. van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB. Predictors of mortality in Staphylococcus aureus bacteremia. Clin Microbiol Rev. 2012;25(2):362-386. 3. Smit J, López-Cortés LE, Kaasch AJ, et al. Gender differences in the outcome of community-acquired Staphylococcus aureus bacteraemia: a historical population-based cohort study. Clin Microbiol Infect. 2017;23(1):27-32. 4. Austin ED, Sullivan SS, Macesic N, et al. Reduced mortality of staphylococcus aureus bacteremia in a retrospective cohort study of 2139 patients: 2007-2015. Clin Infect Dis. 2020;70(8):1666-1674. 5. Mansur N, Hazzan R, Paul M, Bishara J, Leibovici L. Does sex affect 30-day mortality in Staphylococcus aureus bacteremia? Gend Med. 2012;9(6):463-470. 6. Forsblom E, Kakriainen A, Ruotsalainen E, Järvinen A. Comparison of patient characteristics, clinical management, infectious specialist consultation, and outcome in men and women with methicillin-sensitive Staphylococcus aureus bacteremia: a propensity-score adjusted retrospective study. Infection. 2018;46(6): 837-845. 7. Jokinen E, Laine J, Huttunen R, et al. Comparison of outcome and clinical characteristics of bacteremia caused by methicillin-resistant, penicillin-resistant and penicillinsusceptible Staphylococcus aureus strains. Infect Dis (Lond). 2017;49(7):493-500. 8. Kang CK, Kwak YG, Park Y, et al; Korea INfectious Diseases (KIND) study group. Gender affects prognosis of methicillin-resistant Staphylococcus aureus bacteremia differently depending on the severity of underlying disease. Eur J Clin Microbiol Infect Dis. 2018;37(6):1119-1123. 9. McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS Peer Review of Electronic Search Strategies: 2015 guideline statement. J Clin Epidemiol. 2016;75:40-46. 10. Covidence. Covidence systematic review software, Veritas Health Innovation. Accessed October 31, 2022. http:// www.covidence.org 11. Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non randomised studies in meta-analyses. Ottawa Hospital Research Institute website. Accessed January 10, 2023. https:// www.ohri.ca/programs/clinical_ epidemiology/oxford.asp 12. Shor E, Roelfs D, Vang ZM. The “Hispanic mortality paradox” revisited: meta-analysis and meta-regression of life-course differentials in Latin American and Caribbean immigrants’ mortality. Soc Sci Med. 2017;186:20-33. 13. Grant RL. Converting an odds ratio to a range of plausible relative risks for better communication of research findings. BMJ. 2014;348:f7450. 14. Mejer N, Westh H, Schønheyder HC, et al; Danish Staphylococcal Bacteraemia Study Group. Stable incidence and continued improvement in short term mortality of Staphylococcus aureus bacteraemia between 1995 and 2008. BMC Infect Dis. 2012;12:260. 15. Appendix C: The Odds Ratio as an Estimator of the Incidence Rate Ratio. In: Greenberg RS, Daniels SR, Flanders W, et al. Medical Epidemiology, 4th Edition. McGraw-Hill Companies; 2005.
RkJQdWJsaXNoZXIy MTk4NDMw